Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805659 · ClinicalTrials.gov registry record · NA
HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms
A NA study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT03805659 is a NA study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 6 participants.
The verdict
NCT03805659, a NA study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study aims to evaluate the effectiveness of a therapy called High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for the treatment of the language deficits experienced by people with a type of Primary Progressive Aphasia. This study uses a combination of brain imaging, language assessment, language training sessions, and HD-tDCS therapy as well as placebo therapy sessions.
Interventions
- DEVICE Sham
- DEVICE HD-tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2022-05-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03805659
The ClinicalTrials.gov registry entry for NCT03805659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT03805659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03805659 about?
NCT03805659 is a clinical study titled "HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms". This study aims to evaluate the effectiveness of a therapy called High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for the treatment of the language deficits experienced by people with a type of Primary Progressive Aphasia. This study uses a combination of brain imaging, language as...
What is the current status of trial NCT03805659?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-02-24. Estimated completion is 2022-05-18.
What interventions are being tested in trial NCT03805659?
The interventions under investigation include: Sham (DEVICE), HD-tDCS (DEVICE).
Who is sponsoring clinical trial NCT03805659?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.